CFO appointment
Acro Biomedical Co., Ltd. appoints Jing-Zhou Chen as CFO
Acro Biomedical Co., Ltd. reported in a Form 8-K filed September 2, 2026 that Jing-Zhou Chen was appointed chief executive officer and chief financial officer, effective September 2, 2026.
In the filing's words
On September 2, 2026, the Company's board of directors appointed Jing-Zhou Chen as chief executive officer and chief financial officer, effective on September 2, 2026.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Acro Biomedical Co., Ltd. (ACBM) |
|---|---|
| Event | Appointment |
| Incoming | Jing-Zhou Chen |
| Title in the filing | chief executive officer and chief financial officer |
| Effective | September 2, 2026 |
| 8-K filed | September 2, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Chief Executive Officer and founder, Dream Born Co., Ltd. |
| SEC CIK | 0001622996 |
ACRO BIOMEDICAL CO., LTD. reported this change in a Form 8-K, Item 5.02, filed September 2, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Jing-Zhou Chen? Send a correction with the primary source.